EVP & CFO · vTv Therapeutics Inc. · vTv Therapeutics Inc. — Employee stock option (right to buy)
Side
A
Value
$1.66M
Shares
45.0K
Price
$36.92
Executed
Feb 17, 2026
Disclosed
Feb 18, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Feb 17 executedFeb 18, 2026 disclosed
VTVT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+22 / 25
$1.7M reported value · 99.9% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
vTv Therapeutics Inc. — Employee stock option (right to buy)
Ticker
VTVT
Shares
45.0K
Price per share
$36.92
Value
$1,660,255
Execution date (reported)
Feb 17, 2026
Owned after transaction
90.0K shares
Days from execution to publication
1
Calculation
Value = shares × reported price per share
Shares: 45.0K
Price: $36.92
= $1,660,255
What this establishes
Tung Michael Stephen filed this Form 4 reporting a grant or award of VTVT on Feb 17, 2026. It became public on Feb 18, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP & CFO
Tung Michael Stephencik:0002069755
Issuer
vTv Therapeutics Inc.cik:0001641489
Revision history · 0
No field has changed since this record was first ingested.
